Literature DB >> 7905082

Poor metabolisers of nicotine and CYP2D6 polymorphism.

S Cholerton, A Arpanahi, N McCracken, C Boustead, H Taber, E Johnstone, J Leathart, A K Daly, J R Idle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7905082     DOI： 10.1016/s0140-6736(94)90921-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism.

Authors:  Ryoko Yoshida; Miki Nakajima; Yuki Watanabe; Jun-Tack Kwon; Tsuyoshi Yokoi
Journal:  Br J Clin Pharmacol       Date:  2002-11       Impact factor: 4.335

Review 2.  Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotype.

Authors:  A Llerena; J Cobaleda; C Martínez; J Benítez
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

Review 3.  Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese.

Authors:  T Yokoi; T Kamataki
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

4.  Inter-ethnic differences in genetic polymorphisms of xenobiotic-metabolizing enzymes (CYP1A1, CYP2D6, NAT1 and NAT2) in healthy populations: correlation with the functional in silico prediction.

Authors:  Rim Khlifi; Ghada Ben Salah; Amine Chakroun; Amel Hamza-Chaffai; Ahmed Rebai
Journal:  Mol Biol Rep       Date:  2014-06-17       Impact factor: 2.316

5.  A nonsense mutation in the cytochrome P450 CYP2D6 gene identified in a Caucasian with an enzyme deficiency.

Authors:  F Broly; D Marez; J M Lo Guidice; N Sabbagh; M Legrand; P Boone; U A Meyer
Journal:  Hum Genet       Date:  1995-11       Impact factor: 4.132

Review 6.  Tailoring nicotine replacement therapy: rationale and potential approaches.

Authors:  Jennifer B McClure; Gary E Swan
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

7.  Passive smoking by self report and serum cotinine and the prevalence of respiratory and coronary heart disease in the Scottish heart health study.

Authors:  H Tunstall-Pedoe; C A Brown; M Woodward; R Tavendale
Journal:  J Epidemiol Community Health       Date:  1995-04       Impact factor: 3.710

8.  Molecular epidemiological study of non-small-cell lung cancer from an environmentally polluted region of Poland.

Authors:  M Rusin; D Butkiewicz; E Malusecka; A Zborek; J Harasim; K Czyzewski; W P Bennett; P G Shields; A Weston; J A Welsh; S Krzyzowska-Gruca; M Chorazy; C C Harris
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

Review 9.  Polymorphisms in the human cytochrome P450 and arylamine N-acetyltransferase: susceptibility to head and neck cancers.

Authors:  Rim Khlifi; Olfa Messaoud; Ahmed Rebai; Amel Hamza-Chaffai
Journal:  Biomed Res Int       Date:  2013-09-16       Impact factor: 3.411

Review 10.  Tobacco and cancer: epidemiology and the laboratory.

Authors:  P Vineis; N Caporaso
Journal:  Environ Health Perspect       Date:  1995-02       Impact factor: 9.031
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.